EMCDDA news

EU Drug Markets: Drivers and facilitators — new report unveils dynamics of illicit drug market

In a new report out today, EU Drug Markets: Drivers and facilitators, the EMCDDA and Europol, provide valuable insights into the evolving landscape of drug production, trafficking and distribution. The report is a key element in the EU Drug Markets: In-depth analysis from the two agencies, their fourth comprehensive overview of illicit drug markets in the EU. The analysis focuses on three main market drivers: globalisation, technology and innovation, and criminal tools. Globalisation — The report illustrates how globalisation has had a profound impact on illicit drug markets, with…
Čtěte více

EMCDDA teams up with Tunisian partners to deliver EUPC training course

This week, the EMCDDA is holding a European Prevention Curriculum (EUPC) training course in Tunis, Tunisia. The course, covering the EUPC 'basic modules' is being delivered in cooperation with the National Narcotics Office at the Ministry of Public Health and the Tunisian National Institute of Public Health. Some 20 policy-makers and professionals with a role in prevention from Algeria, Morocco and Tunisia are participating in the two-day course, delivered in French by two EUPC master trainers. The EUPC course is designed to train decision-makers, opinion-makers and policy-makers who are…
Čtěte více

A year in review: General Report of Activities 2023 published today

Today, the EMCDDA launches its General Report of Activities 2023, which provides an overview of key achievements and governance in a year steeped in significance. 'No previous year has bridged the future and the past more significantly than 2023 has done', states the report. In February, the EMCDDA commemorated 30 years since its creation, an event which had symbolised a major political decision to build drug policies on scientific evidence rather than ideology. In July, new legislation entered into force, setting the agency on a one-year transition course to becoming the new European…
Čtěte více

EMCDDA launches 2024 European Web Survey on Drugs to assess patterns of drug use in over 30 countries

Do you use drugs? How many? Why? These are among the questions posed in the latest European Web Survey on Drugs, launched today by the EU drugs agency (EMCDDA). Targeted at people, aged 18 and over, who have used drugs, the survey aims to improve understanding of patterns of drug use in Europe and help shape future drug policies and interventions. The voluntary, anonymous survey — one of the agency’s targeted ‘leading-edge’ monitoring methods — will run this year in 36 countries in around 30 languages. As in previous years, it will be promoted nationally by the Reitox focal points and their…
Čtěte více

EMCDDA official visit to Colombia to sign Working Arrangement with Ministry of Justice and Law

This week, EMCDDA Director Alexis Goosdeel is making an official visit to Colombia to sign the agency's Working Arrangement with the Colombian Ministry of Justice and Law. The Ministry — through its Strategic Sub-Directorate for Analysis, under the Directorate for Drug Policy and Related Activities — is responsible for directing, coordinating and managing the National Drugs Observatory. This bilateral Working Arrangement reflects the willingness and commitment from both sides to join forces for mutual benefit. It will also support EU preparedness to face drug-related threats, an issue of…
Čtěte více

Dne 2. července 2024 se centrum EMCDDA stalo Agenturou Evropské unie pro drogy (EUDA).
Web agentury: https://www.euda.europa.eu Informační stránka o novém mandátu centra EMCDDA (agentury EUDA) je na webu EUDA k dispozici i v češtině - OTEVŘÍT Změnily se i e-mailové adresy zaměstnanců agentury, jsou nyní ve formátu jmeno.prijmeni@euda.europa.eu.